R Martino1,2,3, J Ringash4,5, L Durkin1,6, E Greco2, S Hui Huang4, W Xu4, C J Longo7. 1. Department of Speech-Language Pathology, University of Toronto. 2. Rehabilitation Sciences Institute, University of Toronto. 3. Department of Otolaryngology-Head and Neck Surgery, University of Toronto. 4. Department of Radiation Medicine, Princess Margaret Cancer Centre, University Health Network. 5. Department of Radiation Oncology, University of Toronto, and. 6. Department of Speech-Language Pathology, University Health Network, Toronto, ON; and. 7. DeGroote School of Business, McMaster University, Burlington, ON.
Abstract
BACKGROUND: Resource limitations affect the intensity of speech-language pathology (slp) dysphagia interventions for patients with head-and-neck cancer (hnc). The objective of the present study was to assess the feasibility of a prospective clinical trial that would evaluate the effects on health and patient costs of early slp dysphagia intervention for hnc patients planned for curative concurrent chemoradiotherapy (ccrt). METHODS: Patients with hnc planned for curative ccrt were consecutively recruited and received dysphagia-specific intervention before, during, and for 3 months after treatment. Swallowing function, body mass index, health-related quality of life (qol), and out-of-pocket costs were measured before ccrt, at weeks 2 and 5 during ccrt, and at 1 and 3 months after ccrt. Actuarial percutaneous endoscopic gastrostomy (peg) removal rates and body mass index in the study patients and in a time-, age-, and disease-matched cohort were compared. RESULTS: The study enrolled 21 patients (mean age: 54 years; 19 men). The study was feasible, having a 95% accrual rate, 10% attrition, and near completion of all outcomes. Compared with the control cohort, patients receiving dysphagia intervention trended toward a higher rate of peg removal at 3 months after ccrt [61% (32%-78%) vs. 53% (23%-71%), p = 0.23]. During ccrt, monthly pharmaceutical costs ranged between $239 and $348, with work loss in the range of 18-30 days for patients and 8-12 days for caregivers. CONCLUSIONS: We demonstrated the feasibility of comparing health and economic outcomes in patients receiving and not receiving early slp dysphagia intervention. These preliminary findings suggest that early slp dysphagia intervention for hnc patients might reduce peg dependency despite worsening health. Findings also highlight effects on financial security for these patients and their caregivers.
BACKGROUND: Resource limitations affect the intensity of speech-language pathology (slp) dysphagia interventions for patients with head-and-neck cancer (hnc). The objective of the present study was to assess the feasibility of a prospective clinical trial that would evaluate the effects on health and patient costs of early slp dysphagia intervention for hnc patients planned for curative concurrent chemoradiotherapy (ccrt). METHODS: Patients with hnc planned for curative ccrt were consecutively recruited and received dysphagia-specific intervention before, during, and for 3 months after treatment. Swallowing function, body mass index, health-related quality of life (qol), and out-of-pocket costs were measured before ccrt, at weeks 2 and 5 during ccrt, and at 1 and 3 months after ccrt. Actuarial percutaneous endoscopic gastrostomy (peg) removal rates and body mass index in the study patients and in a time-, age-, and disease-matched cohort were compared. RESULTS: The study enrolled 21 patients (mean age: 54 years; 19 men). The study was feasible, having a 95% accrual rate, 10% attrition, and near completion of all outcomes. Compared with the control cohort, patients receiving dysphagia intervention trended toward a higher rate of peg removal at 3 months after ccrt [61% (32%-78%) vs. 53% (23%-71%), p = 0.23]. During ccrt, monthly pharmaceutical costs ranged between $239 and $348, with work loss in the range of 18-30 days for patients and 8-12 days for caregivers. CONCLUSIONS: We demonstrated the feasibility of comparing health and economic outcomes in patients receiving and not receiving early slp dysphagia intervention. These preliminary findings suggest that early slp dysphagia intervention for hnc patients might reduce peg dependency despite worsening health. Findings also highlight effects on financial security for these patients and their caregivers.
Entities:
Keywords:
Head-and-neck cancer; dysphagia interventions; lost income; patient costs; quality of life
Authors: William R Carroll; Julie L Locher; Cheri L Canon; Isaac A Bohannon; Nancy L McColloch; J Scott Magnuson Journal: Laryngoscope Date: 2008-01 Impact factor: 3.325
Authors: Karen Wong; Shao Hui Huang; Brian O'Sullivan; Gina Lockwood; Darlene Dale; Terry Michaelson; John Waldron; Andrew Bayley; Bernard Cummings; Laura A Dawson; John Kim; Geoffrey Liu; Jolie Ringash Journal: Radiother Oncol Date: 2010-03-31 Impact factor: 6.280
Authors: Samuel G Shiley; Christopher A Hargunani; Judith M Skoner; John M Holland; Mark K Wax Journal: Otolaryngol Head Neck Surg Date: 2006-03 Impact factor: 3.497
Authors: Tamar Kotz; Alex D Federman; Johnny Kao; Lyudmila Milman; Stuart Packer; Coral Lopez-Prieto; Kevin Forsythe; Eric M Genden Journal: Arch Otolaryngol Head Neck Surg Date: 2012-04
Authors: Colleen A McHorney; Joanne Robbins; Kevin Lomax; John C Rosenbek; Kimberly Chignell; Amy E Kramer; D Earl Bricker Journal: Dysphagia Date: 2002 Impact factor: 3.438
Authors: Eileen Huh Shinn; Karen Basen-Engquist; George Baum; Sven Steen; Rachel Freeman Bauman; William Morrison; Adam Seth Garden; Cathleen Sheil; Kelly Kilgore; Katherine A Hutcheson; Denise Barringer; Ying Yuan; Jan S Lewin Journal: Head Neck Date: 2013-10-21 Impact factor: 3.147
Authors: R Martino; M I Fitch; C D Fuller; A Hope; G Krisciunas; S E Langmore; C Lazarus; C L Macdonald; T McCulloch; G Mills; D A Palma; K Pytynia; J Ringash; K Sultanem; J Theurer; K E Thorpe; K Hutcheson Journal: BMC Cancer Date: 2021-10-13 Impact factor: 4.430